Estimating The Minimally Clinically Important Difference of the Upper Extremity Scale of the Fugl-Meyer Assessment in Chronic, Severe Stroke Available to Purchase

Date Presented 04/20/2023

Accurate estimates of the minimal clinically significant difference (MCID) of the Upper Extremity scale of the Fugl–Myer Assessment are essential for determining the effectiveness of interventions provided to stroke survivors in the chronic phase with residual severe upper extremity hemiparesis. Previously established values cannot be generalized to stroke survivors in other phases of recovery and with differing severity of residual hemiparesis due to the diversity in level of impairment.

Primary Author and Speaker: Elliot Barden

Additional Authors and Speakers: Kyle O'Laughlin

Contributing Authors: Ela Plow, Jayme Knutson, Xiaofeng Wang, Kaitlin Perlic